Overexpression of FOXC1 has been reported in nearly 20% of primary AML samples, where FOXC1 has been shown to be involved in the monocyte/macrophage differentiation block and in the increased clonogenic potential of AML cells [13–14]. The gene discussed is FOXC1; the disease is acute myeloid leukemia.